ReVance Therapeutics, Inc. To Release Fourth Quarter And Full Year 2013 Financial Results And Host Conference Call On Wednesday, March 26, 2014

NEWARK, Calif., March 12, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), a specialty biopharmaceutical company which develops botulinum toxin products for use in aesthetic and therapeutic indications, today announced that the company will release fourth quarter and full year 2013 financial results on Wednesday, March 26, 2014 after the close of market. Revance will host a conference call and a live Internet webcast at 1:30pm PT/4:30pm ET on the same day to discuss the results and provide a business update.

Help employers find you! Check out all the jobs and post your resume.